Brain fog breakthrough? NIH tests IV drip for long COVID
NCT ID NCT05350774
Summary
This study is testing if a treatment called intravenous immunoglobulin (IVIG) can help reduce neurological symptoms in people with Long COVID, such as brain fog, dizziness, and fatigue. About 45 adults who had COVID-19 at least 12 weeks ago and still have these symptoms will receive either the IVIG treatment or a placebo saline drip for comparison. Researchers will measure changes in thinking, daily function, and quality of life to see if the treatment provides meaningful relief.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.